Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 248-255

  Naya, Masanao ^a   Murthy, Venkatesh L ^a,b   Taqueti, Viviany R ^a   Foster, Courtney R ^a   Klein, Josh ^a   Garber, Mariya ^a   Dorbala, Sharmila ^a   Hainer, Jon ^a   Blankstein, Ron ^a   Resnic, Frederick ^a   Di Carli, Marcelo F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Coronary artery disease; Coronary flow reserve

Indexed keywords

RUBIDIUM 82; TROPONIN; DIAGNOSTIC AGENT; RUBIDIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; CORONARY RISK; DIAGNOSTIC TEST ACCURACY STUDY; DUKE CLINICAL RISK SCORE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; Q WAVE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSIENT ISCHEMIC DILATION INDEX; 82RB PET; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; HEART; METHODOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY; PERFUSION; PERICARDIUM; PROBABILITY; RISK; RISK FACTOR; SCINTISCANNING; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME;

82RB PET; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE;

ADULT; AGED; COHORT STUDIES; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERFUSION; PERICARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK; RISK FACTORS; ROC CURVE; RUBIDIUM RADIOISOTOPES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84897931387     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.121442     Document Type: Article

References (41)

1. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation. 2009;119: e561-e587.
2. Shaw LJ, Hage FG, Berman DS, Hachamovitch R, Iskandrian A. Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol. 2012;19: 1026-1043.
3. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-Term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107: 2900-2907.
4. Fiechter M, Ghadri JR, Gebhard C, et al. Diagnostic value of 13N-Ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53: 1230-1234.
5. Ziadi MC, Dekemp RA, Williams K, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19: 670-680.
6. Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995;91: 1944-1951.
7. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-Artery stenosis. N Engl J Med. 1994;330: 1782-1788.
8. Gould KL, Nakagawa Y, Nakagawa K, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-To-Apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation. 2000;101: 1931-1939.
9. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356: 830-840.
10. Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124: 2215-2224.
11. 82Rb PET: comparison with 13Nammonia PET. J Nucl Med. 2009;50: 1062-1071.
12. 82Rb. J Nucl Med. 2010;51: 1592-1599.
13. 82Rb in humans under pharmacologic stress. J Nucl Med. 2011;52: 485-491.
14. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89: 2015-2025.
15. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464-471.
16. Pryor DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med. 1993;118: 81-90.
17. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 1998;31: 534-540.
18. Naya M, Murthy VL, Blankstein R, et al. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011;58: 1807-1816.
19. 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008;35: 1593-1601.
20. Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14: 521-528.
21. Parkash R, deKemp RA, Ruddy TD, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease [published correction appears in J Nucl Cardiol. 2004;11: 756]. J Nucl Cardiol. 2004;11: 440-449.
22. Campisi R, Czernin J, Schoder H, et al. Effects of long-Term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation. 1998;98: 119-125.
23. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90: 808-817.
24. Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med. 2011;52: 1369-1377.
25. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41: 1387-1393.
26. Iwado Y, Yoshinaga K, Furuyama H, et al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging. 2002;29: 984-990.
27. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 2000;36: 103-109.
28. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol. 1998;32: 147-153.
29. Quercioli A, Pataky Z, Montecucco F, et al. Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging. 2012;5: 805-815.
30. Tsukamoto T,Morita K, NayaM, et al.Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging. 2006;33: 1150-1156.
31. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33: 87-94.
32. Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122: 603-613.
33. Herzog BA, Husmann L, Valenta I, et al. Long-Term prognostic value of 13Nammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54: 150-156.
34. Ziadi MC, Dekemp RA, Williams KA, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58: 740-748.
35. 82Rb PET perfusion imaging. J Nucl Med. 2011;52: 726-732.
36. Tio RA, Dabeshlim A, Siebelink HM, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med. 2009;50: 214-219.
37. McArdle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-Analysis. J Am Coll Cardiol. 2012;60: 1828-1837.
38. Rossen JD, Quillen JE, Lopez AG, Stenberg RG, Talman CL, Winniford MD. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol. 1991;18: 485-491.
39. Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14: 514-520.
40. Bartunek J, Wijns W, Heyndrickx GR, de Bruyne B. Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine. Circulation. 1999;100: 243-249.
41. Panza JA, Holly TA, Asch FM, et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61: 1860-1870.